The long-term side effects of Zantac are many. The most common side effects linked to Zantac and other ranitidine heartburn and reflux medications are temporary in nature and generally, stop when you discontinue use. They may include:
Rarely, serious side effects and adverse events from the usage of Zantac have been reported, according to drug manufacturer Sanofi. The long-term side effects of Zantac may improve once you discontinue using it. Some may require medical care or become long-term concerns. These include:
These side effects are in addition to the allegations that these medications may cause cancer. As of February 19, 2020, the United States Judicial Panel on Multidistrict Litigation reports that there are 140 cases pending in multidistrict litigation 2924, the Zantac cancer case. This number is expected to increase dramatically over the next few months.
According to the manufacturer of over-the-counter brand name Zantac pills, there have been a number of adverse reactions linked to taking ranitidine, especially in higher doses of the prescription formula. A causal relationship has not been proven in every case, but these reported side effects occurred during clinical trials, post-marketing surveillance, and monitoring of patients taking these medications.
Some of the long-term side effects of Zantac include:
There is no doubt that Zantac is effective at reducing acid reflux and heartburn symptoms. However, many people have also reported side effects. Thankfully, most of these are not serious and do not last once the drug is stopped. Headache, malaise, dizziness, vertigo, and other side effects fade quickly without medical attention. Allergic reactions, however, are also possible. Anaphylactic shock is possible after taking a single dose of ranitidine.
Recalls began on Zantac and generic formulations of the drug in September 2019, after it became known that some of these medications might contain a probable carcinogen known as NDMA. This carcinogen is also at the heart of the Valsartan NDMA multidistrict litigation 2875.
Paperwork that’s part of the multidistrict litigation alleges that Zantac and ranitidine can cause tumors at many sites throughout the body, leading to cancer growth in areas that include:
As of February 2020, there are thousands of lawsuits filed based on the dangers of ranitidine drugs and 140 pending in multidistrict litigation 2924.
If you used Zantac or another ranitidine product and later received a cancer diagnosis, you may want to discuss your case with a member of Zanes Law. We can review your case for free and explain your options for pursuing compensation through the multidistrict litigation or another legal action.
Call Zanes Law now at (866) 499-8989 to get started with your free consultation. Your consultation and sign-up can all take place in one phone call.